Key points
In week 40, circulation of SARS-CoV-2 increased again throughout metropolitan France, with a further rise in hospital admissions.
- Metropolitan France:
- Incidence rate above 500/100,000 inhabitants at national level
- Increasingly marked rise in incidence rate among the elderly
- Incidence rate stable among 0-9 year-olds and falling again among 10-19 year-olds
- Number of deaths on the rise
- Overseas France:
- Incidence rate falling or stable at low levels in all territories
Variants
- Omicron sub-lineages: BA.5 omnipresent, accounting for 89% of sequences in the week 39 Flash Survey (26 September)
Prevention
- Vaccination on 10 October 2022 (Vaccin Covid data):
- 74.4% of the population aged 18+ and 82.5% of the 65+ age group had received a first booster dose
- 30.4% of 60-79 year-olds (representing 35.9% of those who are eligible given the time since their last injection) and 37.7% of people aged 80+ (49.3% of those who are eligible) had received a second booster dose
- Given the intense circulation of SARS-CoV-2, compliance with the combined measures remains crucial:
- up-to-date COVID-19 vaccination, including a booster dose of bivalent vaccine (protecting against the original strain and the Omicron variant of Sars-CoV-2) for eligible individuals already vaccinated with a primary course;
- self-isolation in case of a positive test for COVID-19 and/or symptoms;
- continued application of precautionary measures, including wearing a face mask, particularly around vulnerable people and in enclosed spaces favourable to transmission (public transport, large gatherings, etc.), frequent hand washing and ventilation of interiors.
